http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories
-
Dalrada Financial Corporation Finalizes Exclusive Master Distribution Agreement with Applied Technologies of New York
-
CEO of Dalrada Financial Corporation Subsidiary, Genefic, Inc. Discusses Revenue Drivers and Growth in New Interview
-
Dalrada's Brian Bonar Wins San Diego Business Journal's CEO of the Year
-
Dalrada Financial Corporation CEO Discusses Increased Corporate Momentum and Shares Company Updates in New Interview
-
Dalrada Financial Corporation Joins Minority Business RoundTable, Accelerates Government and Private Contract Opportunities
-
Dalrada Financial Corporation Healthcare Subsidiary, Genefic, Inc., Acquires IV Services Infusion Pharmacy
-
Dalrada Financial Corporation Files Form 10-Q, Announces Third Quarter Revenue of $10.3 Million
-
Dalrada Financial Corporation’s Wholly-Owned Subsidiary, Genefic, Inc. Announces New Telemedicine Services, Enters Booming Weight Loss Drug Market
-
Dalrada Financial Corporation Enters $104 Billion Carbon Credit Market with Data Mining Innovation
-
Dalrada Financial Corporation Announces Heat Pump Product Expansion, Enters Home and Residential Heat Pump Market
-
Dalrada Corporation Announces Authorized Share Reduction Highlighting Huge Growth Potential in 8-K Filing
-
Dalrada Files 8-K; Chairman and CEO Shares Exciting News and Provides Future Outlook
-
Dalrada Reports 54.3% Revenue Increase and Positive Net Equity in Annual 10-K
-
Dalrada Technology Spain Reaches Distribution Agreement with JBS Consulting to Build and Install up to 2,300 Heat Pumps
-
Dalrada Technology Spain Announces Agreement with Crown Glory Holding to Build and Install up to 4,500 Heat Pumps
-
Dalrada Corporation Announces Further Global Expansion; Establishes Dalrada Technologies Morocco
-
Genefic’s Achieve Weight-Loss and Wellness Enjoys Impressive Showing at Pharmacy Profit Summit 2023
-
Dalrada’s Genefic Wellness Group Launches New Infusion Clinics to Deliver Successful Alternative Therapies
-
Dalrada’s Genefic Launches Achieve Weight-Loss and Wellness to Target Emerging Weight Loss Market
-
Dalrada’s Energy Services’ Subsidiary Licenses its Intellectual Property and Technical Knowledge to Pando Infrastructure
-
Dalrada Pharmaceutical Subsidiary, Watson Rx Solutions, Earns Prestigious NABP Specialty Pharmacy and Digital Pharmacy Accreditation
-
Dalrada Corporation Announces the Opening of its Heat Pump Showroom in Las Vegas
-
Dalrada Continues Corporate Restructuring Efforts with Streamlined Operations and Leadership to Improve Subsidiary Interaction and Reduce SG&A
-
Dalrada Corporation Announces Further European Expansion, Creates Dalrada Technology Spain, S.L.
-
Dalrada Executes Corporate Restructuring to Increase Focus on Core Climate Technologies Business and Reduce SG&A by Approximately $3 Million Annually
-
Watson Rx Solutions Earns Two Prestigious Pharmaceutical Accreditations from URAC
-
Dalrada Financial Corporation Reports Revenue of $9.5 Million, an Increase of over $4 Million or 80% During Q3 2023
-
Dalrada Corporation Streamlines Board of Directors to Reflect US and Global Expansion
-
Dalrada Energy Services Signs Agreement with AKF Group for Clean Energy Efficiency Building Projects with an Estimated Value of More than $10 Million Annually
-
Dalrada Corporation Appoints Brian Murphy to its Clean Energy Advisory Board
-
Genefic’s Watson Rx Solutions Earns Prestigious NABP Merchant Accreditation
-
Genefic Announces Opening of New Corporate Headquarters in Northern San Diego County
-
Dalrada’s Strong Revenue Generation Includes 23% Growth to $5.3 Million During the Second Quarter of Fiscal 2023
-
Dalrada Technology Ltd. Moves into New UK Headquarters Designated for Clean Energy Technology and Manufacturing
-
Six Leaders Named to Genefic Board of Directors
-
Dalrada Appoints Harvey Hershkowitz as Chairman and CEO of Genefic
-
Dalrada Health Unveils New Operating Structure to Support Significant Growth, Changes Name to Genefic
-
Dalrada Selects New Independent Auditor to Support Current Business Growth
-
Dalrada Health’s Empower Genomics Receives CDC Approval and Funding for Vaccine Initiative
-
Dalrada Reports Continued Growth with $4.3 Million Revenue During First Quarter 2023
-
Dalrada Reports Fiscal 2022 Results, Continues Strong Upward Trajectory in All Four Core Segments
-
University of Arkansas Contracts Dalrada Corporation’s Deposition Technology Ltd. to Build a Plasma Enhanced Chemical Vapor Deposition Tool
-
Dalrada Corporation Acquires Bothof Brothers Construction
-
Dalrada Corporation Announces Delay in Annual Report on Form 10-K
-
Dalrada Corporation Partners with Averett University to Drive Campus-Wide Green Energy Initiatives
-
Dalrada Corporation Brings Metaverse-Based Digital Ecosystem to Averett University
-
Dalrada Corporation Appoints Anuradha Biswas to Board of Directors
-
Abhik Biswas, CTO of Prakat Solutions, Recently Accepted into Forbes Technology Council
-
Dalrada Health Expands Wellness Services to Support Local Athletes and Fans
-
Dalrada Corporation Appoints Heather McMahon to the Dalrada Clean Energy Advisory Board

